Pmu66 - Cost-Effectiveness Analysis of Ixekizumab Versus Secukinumab in Patients With Psoriatic Arthritis and Concomitant Moderate-To-Severe Psoriasis in Spain

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1902

Related search